Retinoschisis
·MeSH: Retinoschisis
Prevalence
5.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| ABO-503 | ABEONA THERAPEUTICS INC. (ABEO) |
Early Phase 1(1)
| Drug | Company |
|---|---|
| ivb102 | SAB BIOTHERAPEUTICS, INC. (SABS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Retinoschisis?
BioSniper tracks 2 drugs in development for Retinoschisis across 2 companies.
How many clinical trials target Retinoschisis?
There are 1 clinical trial targeting Retinoschisis tracked by BioSniper.
What is the prevalence of Retinoschisis?
The estimated prevalence of Retinoschisis is approximately 5.0 per 100,000 population.
Deep-dive into Retinoschisis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis